MAILEN BROCHE: Open Payments
NPI 1982181491 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,800 in 85 payments from 20 companies in 2025. Trend: 2023 $2,061 · 2024 $1,545 · 2025 $1,800
Food & beverage: $1,800
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $357 |
| Phathom Pharmaceuticals, Inc. | 10 | $200 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $167 |
| Janssen Biotech, Inc. | 6 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $136 |
| Madrigal Pharmaceuticals | 4 | $133 |
| Gilead Sciences, Inc. | 2 | $132 |
| Ardelyx, Inc. | 5 | $123 |
| Ipsen Biopharmaceuticals, Inc | 3 | $94 |
| Celltrion USA Inc. | 2 | $45 |
Products named: VOQUEZNA, CREON, XIFAXAN, TREMFYA, REZDIFFRA, IBSRELA, Livdelzi, ENTYVIO.
Industry payments across FL — which companies pay providers there.
